Home › Companies › Vertex Pharmaceuticals Incorporated › 2025-2026
Compiled from SEC Form N-PX filings and Vertex Pharmaceuticals Incorporated’s Form 8-K, filed May 13, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of May 13, 2026: 14 items on Vertex Pharmaceuticals Incorporated’s Form 8-K, filed May 13, 2026: 4 approved · 10 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Vertex Pharmaceuticals Incorporated in the interactive database Compare manager voting policies
These tallies are Vertex Pharmaceuticals Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 13, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Sangeeta Bhatia | 221,280,173 | 1,624,141 | 93,322 | -- | 10,337,217 | 99.2% | Not verified | — |
| Elect Director: Lloyd Carney | 213,048,550 | 9,855,369 | 93,717 | -- | 10,337,217 | 96% | Not verified | — |
| Elect Director: Alan Garber | 219,396,452 | 3,506,604 | 94,580 | -- | 10,337,217 | 98% | Not verified | — |
| Elect Director: Reshma Kewalramani | 221,911,160 | 999,306 | 87,170 | -- | 10,337,217 | 99.5% | Not verified | — |
| Elect Director: Michel Lagarde | 220,336,343 | 2,566,485 | 94,808 | -- | 10,337,217 | 99% | Not verified | — |
| Elect Director: Jeffrey Leiden | 220,333,763 | 2,576,638 | 87,235 | -- | 10,337,217 | 99% | Not verified | — |
| Elect Director: Diana McKenzie | 221,316,590 | 1,590,047 | 90,999 | -- | 10,337,217 | 99.2% | Not verified | — |
| Elect Director: Bruce Sachs | 209,717,815 | 13,186,265 | 93,556 | -- | 10,337,217 | 94% | Not verified | — |
| Elect Director: Jennifer Schneider | 221,301,670 | 1,602,686 | 93,280 | -- | 10,337,217 | 99.2% | Not verified | — |
| Elect Director: Nancy Thornberry | 220,320,992 | 2,583,895 | 92,749 | -- | 10,337,217 | 99% | Not verified | — |
| Proposal 2: Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026: | 223,514,070 | 9,597,395 | 223,388 | -- | 0 | 96% | Approved | — |
| Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2025 compensation program for the Company's named executive officers: | 207,918,843 | 14,522,776 | 556,017 | -- | 10,337,217 | 93% | Approved | — |
| Proposal 4: Based upon the following votes, the shareholders approved the Company's 2026 Stock and Option Plan. | 216,097,268 | 6,523,460 | 376,908 | -- | 10,337,217 | 97% | Approved | — |
| Proposal 5: Based upon the following votes, the shareholders approved a shareholder proposal regarding shareholder right to act by written consent: | 126,892,696 | 95,756,148 | 348,792 | -- | 10,337,217 | 57% | Approved | — |
Source: Vertex Pharmaceuticals Incorporated, Form 8-K, filed with the SEC on May 13, 2026 — read the filing on EDGAR.
Each item below shows how the 1,181 asset managers that disclosed a Vertex Pharmaceuticals Incorporated vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Vertex Pharmaceuticals Incorporated’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 6 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Sangeeta Bhatia
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Sangeeta Bhatia”): 221,280,173 for, 1,624,141 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 205 asset managers below reported 123,691,458 for, 160,009 against, 19,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,368 | 9 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Lloyd Carney
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Lloyd Carney”): 213,048,550 for, 9,855,369 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 205 asset managers below reported 123,163,273 for, 688,193 against, 19,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,822,871 | 20,505 | 0 | 0 | For |
| BlackRock | 9,501,262 | 2,792 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,217 | 550 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,205 | 197 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Alan Garber
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Alan Garber”): 219,396,452 for, 3,506,604 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 205 asset managers below reported 123,660,539 for, 190,928 against, 19,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,359 | 18 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Reshma Kewalramani
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Reshma Kewalramani”): 221,911,160 for, 999,306 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 205 asset managers below reported 123,844,869 for, 6,597 against, 19,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,372 | 4 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Michel Lagarde
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Michel Lagarde”): 220,336,343 for, 2,566,485 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 205 asset managers below reported 123,844,860 for, 6,607 against, 19,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,363 | 14 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Combines 6 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jeffrey Leiden
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Jeffrey Leiden”): 220,333,763 for, 2,576,638 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 205 asset managers below reported 123,665,885 for, 185,582 against, 19,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,364 | 13 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,693 | 23 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Combines 6 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Diana McKenzie
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Diana McKenzie”): 221,316,590 for, 1,590,047 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 205 asset managers below reported 123,839,900 for, 11,567 against, 19,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,372 | 5 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Combines 6 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Bruce Sachs
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Bruce Sachs”): 209,717,815 for, 13,186,265 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 205 asset managers below reported 123,454,929 for, 396,538 against, 19,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,315 | 62 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,672 | 44 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jennifer Schneider
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Jennifer Schneider”): 221,301,670 for, 1,602,686 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 205 asset managers below reported 123,831,107 for, 20,360 against, 19,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,372 | 5 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Nancy Thornberry
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Nancy Thornberry”): 220,320,992 for, 2,583,895 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 205 asset managers below reported 123,839,891 for, 11,576 against, 19,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,363 | 14 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
The 104 asset managers below reported 7,945,219 for, 6,595 against, 12,107,639 abstained, 206 not voted. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 11,506 | 0 | 9,492,548 | 0 | Abstain |
| Vanguard | 2,219,290 | 2 | 1,011 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 0 | 1,084,687 | 0 | Abstain |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| Prudential/PGIM | 517,196 | 0 | 0 | 0 | For |
| Jackson National | 25,290 | 0 | 470,126 | 0 | Mixed |
| Hartford | 463,402 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 391,443 | 0 | Abstain |
| ADVISORS' INNER CIRCLE FUND | 384,411 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 138,951 | 0 | 153,563 | 0 | Mixed |
| Transamerica | 217,773 | 0 | 0 | 0 | For |
| Six Circles Trust | 0 | 0 | 196,313 | 0 | Abstain |
| NEOS ETF Trust | 167,874 | 0 | 0 | 0 | For |
| Global X | 137,782 | 0 | 0 | 0 | For |
| Russell Investments | 109,721 | 0 | 0 | 0 | For |
| Brighthouse | 87,956 | 0 | 19,989 | 0 | Mixed |
| John Hancock | 0 | 0 | 107,309 | 0 | Abstain |
| Calamos | 99,947 | 0 | 0 | 0 | For |
| Cardano Risk Management B.V. | 84,422 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 75,360 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 71,440 | 0 | 0 | 0 | For |
| Natixis | 0 | 0 | 71,244 | 0 | Abstain |
| Gateway Trust | 0 | 0 | 64,879 | 0 | Abstain |
| SEI | 58,186 | 0 | 0 | 0 | For |
Showing the 25 largest of 104 asset managers. See all 104 in the interactive database.
Combines 8 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: Approval of 2026 Stock and Option Plan.
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders approved the Company's 2026 Stock and Option Plan.”): 216,097,268 for, 6,523,460 against — passed, per its Form 8-K filed May 13, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 4 : Based upon the following votes, the shareholders approved the Company's 2026 Stock and Option Plan.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 227 asset managers below reported 123,739,120 for, 521,834 against, 2 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,346 | 30 | 2 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 275,000 | 351,607 | 0 | 0 | Mixed |
| Prudential/PGIM | 503,879 | 53,979 | 0 | 0 | Mixed |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 227 asset managers. See all 227 in the interactive database.
Combines 22 wordings of this item as funds reported it.
93% Approved · of votes cast
Description as filed by funds: Advisory vote to approve named executive officer compensation.
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2025 compensation program for the Company's named executive officers:”): 207,918,843 for, 14,522,776 against — passed, per its Form 8-K filed May 13, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 : Based upon the following votes, the shareholders approved, on an advisory basis, the 2025 compensation program for the Company's named executive officers:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Vertex Pharmaceuticals Incorporated’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Say on Pay” (4 managers, 629 for, 210 against); “Compensation” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,313 | 62 | 2 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,672 | 44 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 964,768 | 9,899 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Fund voting reports, all 196 managers: 123,480,779 for, 231,846 against, 19,991 abstained, 1,206 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 30,487,155 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 21,018,928 | 0 | 0 | 0 | For |
| BlackRock | 11,604,731 | 1,105 | 81 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 10,821,600 | 0 | 0 | 0 | For |
| Invesco | 8,477,107 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 6,117,725 | 0 | 0 | 0 | For |
| State Street | 4,401,999 | 75,253 | 0 | 0 | For |
| Janus Henderson | 4,263,790 | 8,750 | 0 | 0 | For |
| Loomis Sayles | 3,387,219 | 134,712 | 0 | 0 | For |
| AllianceBernstein | 3,406,743 | 0 | 0 | 0 | For |
| Wellington | 3,038,819 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 2,696,307 | 3,063 | 0 | 0 | For |
| Clearbridge Investments, LLC | 2,657,135 | 620 | 0 | 0 | For |
| Vanguard | 2,616,547 | 0 | 0 | 0 | For |
| Northern Trust | 2,223,380 | 22,756 | 0 | 0 | For |
| T. Rowe Price | 2,210,837 | 28,566 | 0 | 0 | For |
| UBS | 0 | 1,926,752 | 0 | 0 | Against |
| Charles Schwab | 1,926,046 | 0 | 0 | 0 | For |
| Winslow Capital Management, LLC | 1,835,898 | 0 | 0 | 0 | For |
| Amundi | 0 | 1,805,464 | 0 | 0 | Against |
| Goldman Sachs | 1,417,575 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 1,368,702 | 0 | 0 | 0 | For |
| Fidelity | 1,329,208 | 0 | 0 | 0 | For |
| Victory Capital | 1,254,218 | 757 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 32,373 | 1,144,946 | 0 | 0 | Against |
Institutional-manager reports, all 1,021 managers: 157,585,633 for, 11,805,454 against, 429,850 abstained, 45,879 not voted, 871 unknown. Showing the 25 largest; see all in the interactive database.
Combines 8 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2026.
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”): 223,514,070 for, 9,597,395 against — passed, per its Form 8-K filed May 13, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 : Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 209 asset managers below reported 123,749,416 for, 120,672 against, 22,989 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,822,872 | 20,504 | 0 | 0 | For |
| BlackRock | 9,502,594 | 1,460 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,672 | 44 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,205 | 197 | 0 | 0 | For |
Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.
Combines 7 wordings of this item as funds reported it.
57% Approved · of votes cast
Description as filed by funds: Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent.
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 5: Based upon the following votes, the shareholders approved a shareholder proposal regarding shareholder right to act by written consent:”): 126,892,696 for, 95,756,148 against — passed, per its Form 8-K filed May 13, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 5: Based upon the following votes, the shareholders approved a shareholder proposal regarding shareholder right to act by written consent:”
Support: 57% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 204 asset managers below reported 67,035,999 for, 56,829,234 against, 19,991 abstained, 206 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 1,862,590 | 21,980,785 | 2 | 0 | Mixed |
| BlackRock | 13,537 | 9,490,517 | 0 | 0 | Against |
| Invesco | 6,870,069 | 363,014 | 0 | 0 | Mixed |
| Fidelity | 71,363 | 6,416,113 | 0 | 0 | Against |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 6,732 | 3,061,984 | 0 | 0 | Against |
| JPMorgan | 0 | 3,042,993 | 0 | 0 | Against |
| Charles Schwab | 550 | 1,860,217 | 0 | 0 | Against |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 1,084,687 | 0 | 0 | Against |
| TIAA | 0 | 1,072,556 | 0 | 0 | Against |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 944,964 | 78,394 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 1,743 | 991,828 | 0 | 0 | Against |
| T. Rowe Price | 0 | 974,667 | 0 | 0 | Against |
| HARBOR FUNDS | 0 | 688,124 | 0 | 0 | Against |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 275,000 | 351,607 | 0 | 0 | Mixed |
| Prudential/PGIM | 38,020 | 519,838 | 0 | 0 | Mixed |
| Dimensional | 0 | 495,835 | 0 | 0 | Against |
| Jackson National | 401,065 | 94,351 | 0 | 0 | Mixed |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 204 asset managers. See all 204 in the interactive database.
Not shown here: this season’s fund filings also report 1 item from the meeting of May 14, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 254,163,953 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 14.35% |
| 2 | Vanguard | 9.38% |
| 3 | BlackRock | 3.74% |
| 4 | Invesco | 2.85% |
| 5 | Fidelity | 2.55% |
| 6 | INVESTMENT CO OF AMERICA | 2.47% |
| 7 | AMCAP FUND | 1.82% |
| 8 | State Street | 1.21% |
| 9 | JPMorgan | 1.20% |
| 10 | Charles Schwab | 0.73% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 12.00% |
| 2 | Capital Research Global Investors | 8.27% |
| 3 | BlackRock | 4.57% |
| 4 | PARAMETRIC PORTFOLIO ASSOCIATES LLC | 4.26% |
| 5 | Invesco | 3.34% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.41% |
| 7 | State Street | 1.76% |
| 8 | Janus Henderson | 1.68% |
| 9 | Loomis Sayles | 1.39% |
| 10 | AllianceBernstein | 1.34% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Capital World Investors | 11.31% | DEF14A |
| BlackRock | 9.43% | 13F |
| The Vanguard Group | 8.77% | DEF14A |
| Capital Research Global Investors. | 6.81% | DEF14A |
| State Street | 4.62% | 13F |
| JPMorgan Chase | 2.77% | 13F |
| Wellington Management | 1.26% | 13F |
| Morgan Stanley | 1.23% | 13F |
| Northern Trust | 1.01% | 13F |
| Invesco | 1.01% | 13F |
Percentages above are of 254,163,953 shares outstanding, as reported by Vertex Pharmaceuticals Incorporated on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Vertex Pharmaceuticals Incorporated’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At Vertex Pharmaceuticals Incorporated's shareholder meeting held May 13, 2026, in the 2025-2026 proxy season, 1,181 asset managers reported how they voted in their SEC Form N-PX filings, covering 17,619 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote to approve named executive officer compensation. — Vertex Pharmaceuticals Incorporated's filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Vertex Pharmaceuticals Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 13, 2026.
Vertex Pharmaceuticals Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.